Inventurus Knowledge Solutions Ltd. (IKS) — key facts
NSE-listed · Healthcare. Data as of 11 Nov 2026 (IST) from InvestSights.
Last close: ₹1,652 (-2.13% day change)
Key ratios
- P/E ratio
- 38.31
- P/B ratio
- 7.94
- ROE (%)
- 25.77
- ROCE (%)
- 31.23
- Debt/Equity
- 0.27
- Dividend yield (%)
- 0
- Market cap (₹ Cr)
- 27,713.53
Forensic checks
Piotroski F-Score: 5/9 · Altman Z-Score: 7.4 · Beneish M-Score: -2.37
InvestSights quality score
74.3/100 — Above Average (descriptive data-driven composite; not a recommendation)
Management guidance track record
- Revenue growth: guided 12percent, delivered 19.89percent (FY26) — exceeded guidance
- EBITDA margin: guided 35percent, delivered 35percent (Q2 FY26) — met guidance
Latest earnings call (Q1 FY27)
AI summary: The single most important signal from this call is the confirmation and recalibration of the TruBridge acquisition economics. Management confirmed that TruBridge's operating EBITDA of ~$68 million is intact — preserving EPS accretion — but simultaneously disclosed that the annualised revenue base is ~$40 million lower than the ~$340 million anticipated pre-close, settling at…
Full analysis on InvestSights
InvestSights is an analytics platform and is not SEBI-registered as a Research Analyst or Investment Adviser. All figures are educational, descriptive data — not investment advice. Consult a SEBI-registered adviser before investing.